Ischemic reperfusion (I/R) injury is a serious problem in the treatment of ischemic heart disease. ) is a cardiac-specific or cardiac-enriched miRNA. This study was aimed to assess the role of miR-208a in I/R injury. H9c2 cells were used to simulate I/R injury in vitro. miR-208a expression level was measured by qPCR. H9c2 cells after simulated I/R injury were transfected with miR-208a mimic, AOS-miR-208a or negative controls. LDH release, MDA and SOD contents were measured by corresponding purchased detection kits, respectively. Cell apoptosis were measured by flow cytometry. Then binding effect of miR-208a on CHD9 3'UTR was detected by Dual-Luciferase activity assay. After miRNA or CHD9 overexpression transfections, expressions of apoptosis-related factors, CHD9, Notch 1, IκBα, and p65 in H9c2 cells after I/R injury were measured by Western blot assay. Results showed that in H9c2 cells after simulated I/R injury, miR-208a was upregulated. The elevated miR-208a expression enhanced the injury of cells and promoted cell apoptosis. miR-208a directly target 3'UTR of CHD9 and negatively regulated CHD9 expression. Overexpression of CHD9 rescued I/R injury that was enhanced by miR-208a mimic transfection. miR-208a was positively related with activation of Notch/NF-B signal pathways via CHD9. In conclusion, miR-208a was a cardiacenriched miRNA and CHD9 is a direct target of miR-208a, which was also related with Notch/NFB signal pathway during I/R injury. miR-208a has potential to be a biomarker for early diagnosis of I/R injury and might be used as a treatment target in clinical treatment of ischemic heart disease.
A cute myocardial infarction (AMI) is one kind of clinical phenomenon in acute coronary syndrome when the ischemic necrosis of the cardiac muscle occurs, characteristic as both myocardial infarction and angina pectoris. 1, 2) AMI is the leading cause of mortality and morbidity of cardiovascular disease worldwide.
3) Restoration of blood supply is the key in rescuing patients with AMI, but ischemic reperfusion (I/R) might exacerbate the injury caused by overloaded intracellular calcium, formations of a large number of oxygen radicals, microvascular endothelial injury, and etc. 4) Regulation of the ischemic heart disease adaptive response became the major interest of researchers.
In the last two decades, studies about microRNAs (miRNAs) have fundamentally transformed our understanding about the regulation of gene networks and represented one of the most exciting areas in modern cardiology researches. More than 1,500 different miRNAs have been identified in human genome, and many of them were proved to be involved in cardiovascular development, function, and development of disease. [5] [6] [7] [8] In the cardiovascular-related miRNAs, miR-208a earned more attention as a heart-enriched miRNA. It was considered as a potential biomarker or therapeutic target for the treatment of heart disease. miR-208a was highly expressed in the heart, and it was described as an important regulator that is involved in stem cell differentiation to cardiomyocytes. 9, 10) There were evidences about the aberrant miR-208 expression that might lead to the rise of heart failure phenotype, resulting in irreversible myocardial injury in humans. 11) However, the mechanism of miR-208a effect on I/R injury is not well understood yet. Studies have confirmed that the notch signaling pathway plays an important regulatory role in the development, pathology, and physiological processes of the cardiovascular system. 12) Gude, et al. found that the notch signaling pathway might play a regulatory role in myocardial ischemic injury and myocardial protection. 13) However, the association between miR-208a and expressions of notch pathway-related factors in human myocardial I/R has no related reports.
Therefore, the present study was aimed to investigate the role of miR-208a in I/R injured H9c2 cells that were used to simulate myocardial I/R injury in vitro and the potential regulation mechanisms. It was known that miRNAs would generally negatively regulate gene expression by controlling complementary target mRNAs and prohibiting the target gene translation into functional proteins. 14) Therefore, the present study will also investigate the target gene of miR-208a in myocardium cells and relationship with notch signaling pathway. This study might deepen the understanding of heart-specific miR-208a and improve the usage of miR-208a as a biomarker in the prediction of AMI and treatment of I/R injury.
Methods
Cell culture: Embryonic rat myocardium-derived cells H9c2 were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Sigma-Aldrich, St. Louis, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; Invitrogen; Carlsbad, CA, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (GIBCO, Grand Island, NY, USA), in a humidified incubator with 95% air and 5% CO2 at 37 .
Simulated myocardial ischemia/reperfusion (I/R):
The simulated myocardial I/R injury in vitro was induced via performing oxygen and glucose deprivation (OGD) followed by reperfusion (OGD/R) in H9c2 cells. OGD was initiated as previously described. 15) In brief, H9c2 cells were seeded into the 35 mm culture plate at a density of 3 × 10 5 cells/well and been cultured in the complete culture medium for 24 hours. Then the medium was changed by serum and glucose-deficient DMEM, and cells were maintained in an anaerobic chamber in the oxygen-free incubator (95% N2 and 5% CO2) at 37 for 10 hours. After that, cells were re-oxygenated by keeping in the culture medium containing 10% FBS and 4.5 mg/mL glucose for 2 hours. After that, cells were incubated under 95% air and 5% CO2 at 37 for another 24 hours. Cells cultured in normal culture medium with 95% air and 5% CO2 at 37 were used as control. Reverse transcription-quantitative polymerase chain reaction (qPCR): Total RNAs from the cultured cells were isolated by Trizol reagent (Invitrogen, USA) according to the manufacturer's instructions. RNA integrity was verified with agarose gel electrophoresis and been purified by RNeasy Mini kit (Qiagen, Germany). The extracted RNA samples were reversed to cDNA by Taqman MicroRNA Reverse Transcription kit (ThermoFisher Scientific, USA). Fast START Universal SYBR Green Master (ROX) (Roche USA) was used for qPCR analysis according to the manufacturer's instructions to measure the relative levels of miR-208a and CHD9 mRNA expression. Each test was carried out in triplicate on the ABI PRISM 7500 Real-time PCR System (Applied Biosystems, Foster City, CA). Data were analyzed according to the 2 -Ct method and normalized to GAPDH or U6 snRNA expressions in each sample. 16) All primers were synthesized by GenePharma (Shanghai, China). Cell transfection: H9c2 cells were seeded into six-well plates at a density of 5 × 10 4 cells/well and been incubated until about 70% confluence. Then cells were respectively transfected with miR-208a mimics, scramble control, AOS-miR-208a, ASO negative control, or CHD9 overexpression vector, empty control (GenePharma, shanghai, China) for 48 h by using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. Subsequent experiments were performed 24 h after miRNA transfection. Detection of LDH release, MDA, and SOD: The contents or release of specific marker enzymes in the cells after I/R administration, including lactate dehydrogenase (LDH), malondialdehyde (MDA), and superoxide dismutase (SOD), were measured by using corresponding commercial kits that were purchased from Sangon Biotech (Shanghai, China) according to the manufacturer's instructions. Apoptosis assay: Cell apoptosis was assessed by using the APO Percentage assay kit (Biocolor Ltd., UK) according the manufacturer's instructions. Briefly, H9c2 cells after treatment were plated on 24-well plates at the density of 1 × 10 5 cells/well. After incubation for 24 hours, cells were collected and stained by the APO percentage dye. The apoptotic cells were analyzed by flow cytometry on a Becton Dickinson FACScan instrument (BD Pharmingen , USA). Dual-luciferase activity assay: According to the predicted result, sequence of CHD9 3'untranslated region (UTR) wild type (wt), containing the potential target sites of miR-208a, was amplified by PCR and placed in the pmiR-Report vector (Ambion). Mutation of the putative miR-208a target sits in the 3'UTR of CHD9 (Mut) served as control was achieved by using QuickChange SiteDirected Mutagenesis Kit (Stratagene, Heidelberg, Germany). The vectors were co-transfected with miR-208a mimic, AOS-miR-208a or the negative control into cells by using Lipofectamine 2000 (Invitrogen, USA). After 48 hours, Firefly and Renilla luciferase activities were measured by the Dual-Luciferase Reporter assay kit (Promega, USA) according to the manufacturer's information. 17) Western blot assay: Cells after treatment were lysed by using RIPA lysis buffer (Beyotime, Shanghai, China) supplemented with inhibitor cocktails about protease and phosphatase (Roche, Guangzhou, China). Protein concentration was quantified by Bradford assay (Thermo, Hercules, CA, USA). The Western blot system was established by using a Bio-Rad Bis-Tris Gel system and polyvinylidene fluoride (PVDF) membranes according to the manufacturer's instruction. The membranes were blocked with primary antibodies in 5% skim milk at a dilution of 1: 1000 and incubated overnight at 4 , followed by incubation with secondary antibodies marked by horseradish peroxidase for 1 hour at room temperature. Images of bands were visualized by using an enhanced chemiluminescent detection kit (USBiological, Massachusetts, USA) according to the manufacturer's instructions, and quantified by using Quantity One software (Bio-Rad Laboratories, Inc.). The primary antibodies were as follows: notch intracellular domain (NICD, ab83232, Abcam, USA); B-cell lymphoma-2 (Bcl-2, sc56015) (Santa Cruz Biotechnology, USA); Bax (sc6236); chromodomain helicase DNA binding protein 9 (CHD9, sc98634); Notch1 (sc376403); IκBα (sc7977); p65 (sc56735); and GAPDH (sc47724) acted as internal control. Statistical analysis: All samples were run in triplicate, and experiments were repeated at least five times. Data were presented as mean ± standard deviation. Statistical analysis was performed by using GraphPad statistical software 6.1 (GraphPad Software, LA Jolla, CA, USA). Statistical differences were determined by using Student's t test for two groups, or a one-way analysis of variance followed by the Tukey-Kramer multiple comparisons test. The P value of < 0.05 was considered as statistically significant.
Results

miR-208a was upregulation in H9c2 cells after I/R injury:
Expressions of miR-208a after simulated I/R injury were measured by qPCR. The results in Figure 1A showed that the expression level of miR-208a in H9c2 cells after simulated I/R injury was significantly increased compared with that in normal cells as control (P < 0.05). It suggested that miR-208a was upregulated in simulated I/R injured cells in vitro. In addition, transfection efficiency of miR-208 mimic and ASO-miR-208a in H9c2 cells were also assessed by qPCR. Results in Figure 1B showed that miR-208a expression level was markedly regulated by miRNA transfection and that miR-208a mimic transfection increased miR-208a expression in H9c2 cells compared with scramble control (P < 0.01) and ASO-miR-208a transfection decreased the expression of miR-208a compared with ASO-negative control (P < 0.05). miR-208a enhanced I/R injury of H9c2 cells: As an important sign of cell damage, the LDH release of H9c2 cells was measured. In Figure 2A , the results showed that after simulated I/R injury, the LDH release was increased compared with the control group (P < 0.01). miR-208a mimic transfection further aggravated the increased LDH release compared with that in I/R group (P < 0.05), whereas the LDH release was decreased after ASO-miR- Figure 2D suggested that apoptotic cells was increased after I/R injury compared with the normal control group (P < 0.001). miR-208a mimic transfection increased apoptosis of H9c2 cells compared with I/R alone (P < 0.01), whereas ASO-miR-208a transfection decreased apoptosis of H9c2 cells compared with cells simulated with I/R injury alone (P < 0.05). The protein and mRNA expression levels of Bcl-2 and Bax were also assessed. Results in Figures 2E, 2F suggested that simulated I/R injury decreased Bcl-2 expression in cells compared with normal cells (P < 0.01), and miR-208a mimic transfection enhanced the inhibition effect on Bcl-2 expression (P < 0.05), whereas ASO-miR-208a transfection increased Bcl-2 expression compared with I/R injury treatment alone (P < 0.05). For Bax expression, I/R injury increased Bax expression in both mRNA (P < 0.01) and protein levels, whereas miR-208 mimic transfection enhanced this promotion effect on Bax expressions (P < 0.05). ASO-miR208a transfection decreased Bax expression compare with I/R alone (P < 0.05). These results suggested that miR208a promoted H9c2 cell apoptosis after I/R injury. shown in Figure 3A . The targeting effect of miR-208a on CHD9 3'UTR in H9c2 cells were detected. The luciferase activity analysis results in Figures 3B, 3C showed that miR-208a significantly decreased the fluorescence signal intensity of CHD9 3'UTR (wt) group (P < 0.01), whereas non-significant effect on CHD9 3'UTR (Mut). Meanwhile, ASO-miR-208a transfection significantly increased the intensity of fluorescence signal in CHD9 3'UTR (wt) group (P < 0.01), suggesting that miR-208a could bind with the 3'UTR of CHD9.
The expressions of CHD9 in H9C2 cells after miR-208 transfections were also measured in both protein (Figures 3D, 3E ) and mRNA levels ( Figure 3F ). Results showed that miR-208a mimic transfection significantly decreased CHD9 expressions (P < 0.01 in both protein and mRNA levels), whereas ASO-miR-208a transfection increased expressions of CHD9 in mRNA and protein level (P < 0.05 in protein level, and P < 0.01 in mRNA expression level). All these results suggested that CHD9 was a direct target of miR-208a in H9c2 cells and miR-208a negatively regulated expression of CHD9. CHD9 rescued H9c2 cell simulated I/R injury enhanced by miR-208a: On the basis of the above results, we found that miR-208a enhanced H9c2 cell I/R injury and negatively regulated CHD9 expression via targeting effect. Then we assessed the effect of exogenous overexpression of CHD9 on H9c2 cells after simulated I/R injury. The results shown in Figure 4A -C suggested that in simulated I/R injury of H9c2 cells, miR-208a mimic transfection enhanced the LDH release, as well as the levels of MDA and SOD compared with I/R groups (P < 0.05). Overexpression of CHD9 in I/R inured H9c2 cells significantly decreased these three factor levels compared with I/R groups (P < 0.05). Although co-transfection with miR-208 mimic and CHD9 overexpression inhibited the increases in miR-208a mimic transfection group (P < 0.05 or P < 0.01), and miR-208 mimic + CHD9 overexpression under I/R increased LDH release, MDA level and SOD level compared with I/R + pcDNA-CHD9 group (P < 0.05). Similarly, rescuing effects of CHD9 overexpression were also found in the results of apoptosis assay, including decreased apoptotic cells compared with miR-208a mimic alone under I/R (P < 0.01 Figure 4D ). The mRNA ( Figure 4E ) and protein ( Figure 4F ) expression levels of apoptosis-related factors (Bcl-2 and Bax) and CHD9 were all changeover in miR-208a mimic + CHD9 overexpression groups under I/R compared with miR-208a mimic alone (P < 0.05). These results suggested that overexpression of CHD9 might rescue cell damage of H9c2 induced by miR-208a upregulation under simulated I/R injury situation in vitro. miR-208a promoted H9c2 cell I/R injury via notch/NF-Zhang, ET AL κB signal pathway: In order to further study the molecular mechanism of miR-208a that could enhance H9c2 cell I/R damage, we explored the effect of miR-208a on related signaling pathways. Results in Figures 5A, 5B showed that mRNA and protein expression level of Notch1 and NICD were increased after simulated I/R injury (P < 0.01 for mRNA expression level) and miR-208a mimic transfection further improved their increased expressions in H9c2 cells compared with that in I/R groups (P < 0.001 for mRNA level). While ASO-miR-208a transfection decreased the expressions of Notch1 and NICD compared with I/R group (P < 0.05 for mRNA level). The similar situation was found in Figures 5C, 5D for NF-κB signal pathway. miR-208a mimic transfection further increased the expressions of IκBα and p65 compared with the I/R group (P < 0.001, or P < 0.001 for mRNA level), while ASO-miR-208a transfection decreased IκBα and p65 expressions in H9c2 cells compared with the I/R group (P < 0.05). Combine with the negative regulation effect of miR-208a on the expression of CHD9, these results suggested that miR-208a improved the activation of Notch/NF-κB signal pathway via regulating CHD9 expression. Accordingly, we speculated that miR-208a effect on H9c2 cells during simulated I/R injury might be via notch/NF-κB signal pathways.
Discussion
The current clinical treatment strategy for cardiovascular disease caused by ischemia is mainly focused on I/ R. 18, 19) I/R usually caused arrhythmia, ultrastructural changes of myocardial, and I/R injures. 20) The remodeling of cardiac function is a complex process, with the involvement of many molecular regulations. Therefore, understanding about the mechanism of myocardial I/R injury is important to improve the clinical treatment of cardiovas- , and CHD9 were measured by Western blot analysis. GAPDH acted as internal control. *P < 0.05; **P < 0.01; ***P < 0.001. I/R indicates ischemia-reperfusion; and Control indicates cells without simulation of I/R injury. cular disease. 21) In this study, we investigated I/R injury at molecular level by using a simulated I/R cell model in vitro and found that miR-208a was upregulated in H9c2 cells in response to I/R stimulation. Our results also suggested that miR-208a upregulation could accelerate the cellular damage that was induced by I/R. CHD9 was a direct target of miR-208a in H9c2 cells, and it could rescue H9c2 cell to reduce damage. Effect of miR-208a on I/R injury was related with the activation of notch/NF-κB signal pathways via regulating expression of CHD9. It suggested that miR-208a upregulation might be a risk factor of I/R injury and a promoter of I/R injury. miRNAs are involved in the function and dysfunction of heart critically under both physiological and pathophysiological conditions. 22) miR-208a belongs to a highly conserved miR-208 family, including miR-208a/b and miR-499. They were believed to be cardiac-specific or cardiac-enriched miRNAs.
23) The miR-208 family was proved to control myosin content and muscle performance and involved in maintaining functionality and survival of cardiac muscle cells. 24, 25) Recently, researches have verified that miR-208a could sufficiently induce arrhythmias and cardiac remodeling and regulate the component expression in hypertrophy pathway, as well as the cardiac conduction system. 26) In the present study, miR-208a was proved to be upregulated in H9c2 cells after the simulated I/R injury, and miR-208a also exhibited the effect of promoting on cell injury, suggesting that miR-208a, as a cardiacenriched miRNA, was also involved in I/R injury. In cardiac pathology, the existing researches suggested that circulating levels of cardiac miRNAs were significantly elevated, making miRNAs to be the promising diagnostic markers for early diagnosis of AMI. 27) The identification of miR-208a in the bloodstream led to a great clinical interest that suggested that miR-208a has potential to be used as a promising noninvasive biomarker for myocardial injury. 28) On the basis of our results that miR-208a upregulation promoted myocardial cells I/R injury response in vitro, we inferred that miR-208a might be a novel molecular diagnostic marker for early diagnosis of AMI and have the potential to be a treatment target for I/ R injury in clinical therapy.
miRNAs play a crucial role in the regulation of gene expression, and it negatively regulates the expression of its target gene via binding with the 3'UTR of target gene promotor. 23, 29) In addition, miR-208a was essential to the expressions of genes that were involved in cardiac hypertrophy and fibrosis. 30) In the present study, we found that miR-208a regulated CHD9 expression via binding effect, suggesting that CHD9 was a direct target of miR-208a. We also found that overexpression of CHD9 could prevent H9c2 cells from simulated I/R injury. It is known that CHD9 plays an important role in chromatin regulation and association with rDNA genes and the already known transcript control effect of CHD9 on tissue specific genes. 31, 32) Our findings in this study supported the functions of CHD9 that it could protect cells against I/R injury. And thus the completed interactions network of protein-DNA and miRNA-mRNA were established in H9c2 cells. This result enhanced the regulation effect of miR-208a on the heart organogenesis and functions. The rescue effect of CHD9 on I/R injury might provide a potential therapeutic strategy for heart disease after I/R injury.
In order to explore the potential mechanism of miR208a regulation in I/R injury, we also examined the effect of miR-208a on activation of notch/NF-κB signal pathway. Notch signaling pathway is a highly conserved cell signaling system that is implicated in many developmental processes of most multicellular organisms. Notch pathway is a critical component for cardiovascular formation and morphogenesis. 33) Activation of Notch1 signaling in cardiogenic mesoderm induced abnormal heart morphogenesis in mouse. 34) Studies have shown that Notch1 mutations cause defects in aortic valve formation in humans. 35) Notch pathway is associated with PI3K/AKT/NF-κB pathway, which plays important roles in the regulation of myocardial I/R. 34) Moreover, several studies suggested the cross-talk between miRNAs and notch signaling, such as miR-34a and miR-146a. 6, 36, 37) The activated notch signal pathway could induce the activation of NF-κB pathway. 38) However, the exact role of Notch1 in I/R injury was not well known, and it is not yet clear whether Notch/NF-κB signal pathway activity is involved in I/R injury. According to the important role of both miR-208a and notch signaling pathway in myocardial cells, we found that miR208a was positively related with the activation of notch/ NF-κB signaling pathway. Our results also suggested that miR-208a and I/R synergistically promoted activation of signal pathway that might be via negatively regulating expression of CHD9. These findings about the relationship between miR-208a and notch/NF-κB signal pathways might deepen the understandings about I/R injury and provide a theoretical basis for clinical treatment of I/R heart disease in the future.
In conclusion, the present study further confirmed the expression and function of miR-208a in H9c2 cells after simulated I/R injury and explored the regulation effect of miR-208a on notch/NF-κB signal pathways. The further study in vivo and in animal models about miR-208a as a potential biomarker for clinical diagnosis will be helpful in the early diagnosis and post-injury treatment of myocardial ischemia-induced disease.
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